Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Clover Health Investments, Corp. (CLOV : NSDQ)
 
 • Company Description   
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.

Number of Employees: 570

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.56 Daily Weekly Monthly
20 Day Moving Average: 9,384,480 shares
Shares Outstanding: 508.92 (millions)
Market Capitalization: $1,302.83 (millions)
Beta: 1.86
52 Week High: $4.87
52 Week Low: $1.24
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -16.20% -19.93%
12 Week -30.43% -40.58%
Year To Date -18.73% -23.88%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3401 Mallory Lane Suite 210
-
Franklin,TN 37067
USA		 ph: 201-432-2133
fax: -		 investors@cloverhealth.com http://www.cloverhealth.com
 
 • General Corporate Information   
Officers
Andrew Toy - Chief Executive Officer and Director
Vivek Garipalli - Executive Chairman and Director
Peter Kuipers - Chief Financial Officer
Chelsea Clinton - Director
Demetrios L. Kouzoukas - Director

Peer Information
Clover Health Investments, Corp. (HLIS)
Clover Health Investments, Corp. (AZTA)
Clover Health Investments, Corp. (APYI)
Clover Health Investments, Corp. (RNVA)
Clover Health Investments, Corp. (HMSY)
Clover Health Investments, Corp. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 18914F103
SIC: 6324
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 508.92
Most Recent Split Date: (:1)
Beta: 1.86
Market Capitalization: $1,302.83 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.11 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 23.27
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.86
Price/Cash Flow: -
Price / Sales: 0.88
EPS Growth
vs. Year Ago Period: 100.00%
vs. Previous Quarter: 100.00%
Sales Growth
vs. Year Ago Period: 33.27%
vs. Previous Quarter: 37.21%
ROE
06/30/25 - -
03/31/25 - -7.42
12/31/24 - -14.45
ROA
06/30/25 - -
03/31/25 - -4.00
12/31/24 - -7.28
Current Ratio
06/30/25 - -
03/31/25 - 1.54
12/31/24 - 1.61
Quick Ratio
06/30/25 - -
03/31/25 - 1.54
12/31/24 - 1.61
Operating Margin
06/30/25 - -
03/31/25 - -1.68
12/31/24 - -3.43
Net Margin
06/30/25 - -
03/31/25 - -1.69
12/31/24 - -3.14
Pre-Tax Margin
06/30/25 - -
03/31/25 - -1.64
12/31/24 - -3.37
Book Value
06/30/25 - -
03/31/25 - 0.66
12/31/24 - 0.68
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©